Pre-earnings options volume in Adma Biologics (ADMA) is 1.5x normal with calls leading puts 13:2. Implied volatility suggests the market is anticipating a move near 13.3%, or $2.63, after results are released. Median move over the past eight quarters is 8.8%.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADMA: